Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
425 GBX | -0.35% | -3.89% | -3.58% |
03:33pm | Corporate results bound the become the next catalyst for markets | |
01:47pm | JPMorgan Resumes Rentokil Initial Coverage with Neutral Rating | MT |
Sales 2024 * | 5.53B 6.85B | Sales 2025 * | 5.81B 7.19B | Capitalization | 10.71B 13.27B |
---|---|---|---|---|---|
Net income 2024 * | 400M 496M | Net income 2025 * | 525M 650M | EV / Sales 2024 * | 2.48 x |
Net Debt 2024 * | 3B 3.71B | Net Debt 2025 * | 2.67B 3.3B | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
27.5
x | P/E ratio 2025 * |
20.8
x | Employees | 62,931 |
Yield 2024 * |
2.11% | Yield 2025 * |
2.38% | Free-Float | 98.9% |
Latest transcript on Rentokil Initial plc
1 day | -0.06% | ||
1 week | -3.64% | ||
Current month | -9.67% | ||
1 month | -8.13% | ||
3 months | +5.92% | ||
6 months | -7.71% | ||
Current year | -3.33% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Director of Finance/CFO | - | 06-12-31 | |
Brian Webb
COO | Chief Operating Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David J. Frear
BRD | Director/Board Member | 67 | 22-09-30 |
Richard Solomons
CHM | Chairman | 62 | 19-02-28 |
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 5 M€ | +5.20% | ||
0.84% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 425 | -0.35% | 3 961 366 |
24-04-22 | 426.5 | +0.90% | 19,314,430 |
24-04-19 | 422.7 | +2.37% | 13,899,590 |
24-04-18 | 412.9 | -7.61% | 33,763,260 |
24-04-17 | 446.9 | +1.06% | 9,659,211 |
Delayed Quote London S.E., April 23, 2024 at 09:20 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.33% | 13.21B | |
-2.77% | 20.57B |
- Stock Market
- Equities
- RTO Stock